Account
Inquiry
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that has shown promising results in weight management studies. This semaglutide pill alternative compound is presented as a white lyophilized powder with high purity levels exceeding 99%, making it suitable for various research applications.
The product is carefully packaged in sterile vials containing 5mg, 10mg, 15mg, or 30mg of Tirzepatide, with 10 vials per box. Proper storage conditions are crucial for maintaining stability - short term storage at 0-4°C and long term storage at -20°C is recommended to preserve the compound's integrity for extended periods exceeding two years.
As a manufacturer specializing in peptide production, we maintain strict quality control measures throughout the manufacturing process. Each batch undergoes rigorous testing to ensure consistent purity and quality. The semaglutide pill alternative Tirzepatide is supplied for research purposes only and is not intended for human consumption.
Researchers appreciate the consistent quality and reliable supply of this semaglutide pill alternative compound. The product has gained positive feedback from research institutions studying metabolic disorders and weight management mechanisms. Our manufacturing capabilities allow for both small trial orders and large bulk quantities to meet diverse research needs.
The semaglutide pill alternative Tirzepatide represents an important compound in the study of GLP-1 receptor agonists and their potential applications. Researchers should handle this material with appropriate laboratory safety protocols and storage conditions to maintain its research integrity.
